We are live on
!
Find out more
BC
Bruce & Co Portfolio holdings
AUM
$350M
1-Year Est. Return
33.5%
This Fund
S&P 500
This Quarter
Est. Return
+12.93%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$287M
AUM Growth
-$6.85M
(-2.3%)
Cap. Flow
-$32.6M
Cap. Flow
% of AUM
-11.38%
Top 10 Holdings %
Top 10 Hldgs %
72.59%
Holding
37
New
–
Increased
3
Reduced
15
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Darling Ingredients
DAR
|
+$3.18M |
| 2 |
Vicor
VICR
|
+$441K |
| 3 |
Personalis
PSNL
|
+$194K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$7.59M |
| 2 |
Allstate
ALL
|
+$3.91M |
| 3 |
AbbVie
ABBV
|
+$3.64M |
| 4 |
Xcel Energy
XEL
|
+$3M |
| 5 |
AT&T
T
|
+$2.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.78% |
| 2 | Utilities | 28.46% |
| 3 | Industrials | 19.55% |
| 4 | Communication Services | 6.73% |
| 5 | Financials | 6.31% |
Similar funds
RFS
WMP
PCM
SA
MC
KFG
LAS
GAA
Bruce & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bruce & Co held 37 positions worth $287M, down 2.3% from $293M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Bruce & Co withdrew a net $32.6M in Q4 2023, reducing 15 holdings. Its largest reduction was Pfizer, cutting an estimated $7.59M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 34% a quarter earlier, followed by Utilities and Industrials.
Against the trend, Bruce & Co added an estimated $3.18M to Darling Ingredients.
- Bruce & Co added most to Darling Ingredients in Q4 2023, an estimated $3.18M increase.
- Bruce & Co's biggest Q4 2023 reduction was Pfizer, cutting an estimated $7.59M.
- Bruce & Co's ten largest holdings make up 73% of its $287M portfolio in Q4 2023.
- Bruce & Co opened 0 new positions and closed 0 in Q4 2023.
- Bruce & Co's portfolio value fell 2.3% quarter-over-quarter to $287M.
Based on Bruce & Co's 13F filing for Q4 2023, filed 12 Feb 2024.